A closer look at Abercrombie & Fitch Co (ANF) is warranted

While Abercrombie & Fitch Co has overperformed by 1.15%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ANF fell by -59.24%, with highs and lows ranging from $187.80 to $65.40, whereas the simple moving average fell by -33.63% in the last 200 days.

On April 21, 2025, Barclays started tracking Abercrombie & Fitch Co (NYSE: ANF) recommending Equal Weight. A report published by Telsey Advisory Group on March 06, 2025, Reiterated its previous ‘Outperform’ rating for ANF. UBS also Upgraded ANF shares as ‘Buy’, setting a target price of $220 on the company’s shares in a report dated January 10, 2025. JP Morgan Reiterated the rating as Overweight on December 20, 2024, but set its price target from $201 to $204. Raymond James initiated its ‘Outperform’ rating for ANF, as published in its report on December 06, 2024. Citigroup’s report from August 30, 2024 suggests a price prediction of $190 for ANF shares, giving the stock a ‘Buy’ rating. Telsey Advisory Group also rated the stock as ‘Outperform’.

Analysis of Abercrombie & Fitch Co (ANF)

Further, the quarter-over-quarter increase in sales is 7.50%, showing a positive trend in the upcoming months.

One of the most important indicators of Abercrombie & Fitch Co’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 46.98% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.83, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and ANF is recording 2.78M average volume. On a monthly basis, the volatility of the stock is set at 4.88%, whereas on a weekly basis, it is put at 2.97%, with a loss of -4.01% over the past seven days. Furthermore, long-term investors anticipate a median target price of $112.62, showing growth from the present price of $75.84, which can serve as yet another indication of whether ANF is worth investing in or should be passed over.

How Do You Analyze Abercrombie & Fitch Co Shares?

The Apparel Retail market is dominated by Abercrombie & Fitch Co (ANF) based in the USA. When comparing Abercrombie & Fitch Co shares with other companies under Consumer Cyclical, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 7.47, there is a growth in quarterly earnings of -25.69%.

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.52%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 107.56% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

ANF shares are owned by institutional investors to the tune of 107.56% at present.

Hot this week

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

Topics

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

A stock that deserves closer examination: Perpetua Resources Corp (PPTA)

While Perpetua Resources Corp has overperformed by 2.68%, investors...

Perspective Therapeutics Inc (CATX) deserves deeper analysis

While Perspective Therapeutics Inc has underperformed by -2.27%, investors...

Was Foremost Clean Energy Ltd (FMST)’s session last reading good?

While Foremost Clean Energy Ltd has overperformed by 2.80%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.